Top Markets
Coin of the day
Lite Strategy, Inc. Lite Strategy, Inc.

Lite Strategy, Inc.

LITS
Rank in Stocks #27429
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm,... Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was previously known as MEI Pharma, Inc., officially changed its designation to Lite Strategy, Inc. in September 2025. The company was established in 2000 and has its principal operations located in San Diego, California.
Share Price
$0.96
Market Cap
$32.66M
Change (1 day)
2.13%
Change (1 year)
-
Country
US
Trade Lite Strategy, Inc. (LITS)

Category

P/S ratio for Lite Strategy, Inc. (LITS)
P/S ratio as of 2026 TTM: 0
According to Lite Strategy, Inc. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Lite Strategy, Inc. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
2.95 -
AU
11.28 -
US
- -
CH